Hero Image

about Us

A Culture of Innovation

Leveraging HUMAN BIOLOGY + TECHNOLOGY to ignite a new era in human health

About Emulate

At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology.

By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro models that empower researchers to explore the biological mechanisms of health and disease. These microphysiological systems (MPS), commonly known as Organ-Chips, are setting a new standard for how we study biology and develop drugs, therapies, and cures for those who need them most. 

History

A History of Innovation

From the beginning, the goal was always to build a more predictive model of human physiology.

Science Translational Medicine

The pioneering work on Organ-Chips was begun by our founding team at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Following the landmark paper in Science, “Reconstituting Organ-Level Lung Functions on a Chip,” Emulate was founded to share the success of these efforts with the broader life sciences community. Since our inception, we have been focused on delivering exceptional science across multiple organs and applications.

In 2019, Emulate researchers published a pivotal paper in Science Translational Medicine demonstrating how the mechanisms of drug-induced liver injury can be dissected using the Emulate Liver-Chip. In 2022, the landmark publication “Performance assessment and economic analysis of a human Liver-Chip for predictive toxicology” was released in Nature Communications Medicine. This first-of-its-kind study proved that the Emulate human Liver-Chip better predicted drug-induced liver injury than animal and hepatic spheroid models.

Leadership

The Emulate executive team brings steep commercial, technology, and scientific experience from across the life sciences industry. Together, they represent our team, culture and the broader research community in delivering on the promise of predictive human biology.

}

Jim Corbett

CEO, Board Member

}

Donald Ingber

Scientific Founder, Board Member, Scientific Advisory Board Chairman

}

Daniel Levner

Co-Founder, CTO, Board Member

}

Scott Kantor

Chief Financial Officer

}

Lorna Ewart

Chief Scientific officer

}

Veronica Mankinen

VP, Sales

}

Jenn Perkins

VP, Marketing

}

Josiah Sliz

VP, Platform Development

}

Stacy Perro

VP, People

}

Ernie Ansah

Senior Director, Quality Management

}

Luke Dimasi

Senior Director, Product Management

Board of Directors

}

Martin Madaus

Executive Chairman

}

Donald Ingber

Board Member

}

Jim Corbett

Board Member

}

Sharon Kedar

BOARD MEMBER

}

Daniel Levner

BOARD MEMBER

}

Shlomo Melmed

BOARD MEMBER

}

Eric Moessinger

BOARD MEMBER

}

Franklin Witney

BOARD MEMBER

}

Aaron VanDevender

BOARD MEMBER

NEWSROOM

Interested in what others are saying about Emulate? Read on.

EVENTS

Hear from our customers and scientists on progress being made within the MPS world.